Screening/lab tests offer huge savings for US healthcare system, says report
This article was originally published in Clinica
A genetic test that enables improved treatment of patients with metastatic colorectal cancer could save $740m annually in costs to the US healthcare system, according to a new report promoting the benefits of screening and lab tests.
You may also be interested in...
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.